The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the latest in a string of leadership changes at the agency.FDA Commissioner Marty ...

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

FDA names former pharmaceutical company executive to oversee US drug program by: MATTHEW PERRONE, Associated Press Posted: Jul 21, 2025 / 10:46 AM CDT Updated: Jul 21, 2025 / 10:49 AM CDT ...